
Key session speakers and abstract presenters share their highlights of attending AAD 2026.
Linda Stein Gold, MD
Director of Dermatology Clinical Research
Henry Ford Health System
Detroit, MI

Key session speakers and abstract presenters share their highlights of attending AAD 2026.

Linda Stein Gold, MD, shares efficacy and safety findings from the ICONIC-ADVANCE studies in moderate to severe psoriasis.

Linda Stein Gold, MD, shares recent findings from the pooled phase 3 analysis of the ADORING 1 and ADORING 2 trials for atopic dermatitis.

Linda Stein Gold, MD, shares insights on new therapeutic options for patients with various psoriasis subtypes and psoriatic arthritis.